199 related articles for article (PubMed ID: 22523289)
1. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors.
Lavalle GE; De Campos CB; Bertagnolli AC; Cassali GD
In Vivo; 2012; 26(3):375-9. PubMed ID: 22523289
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
Arenas C; Peña L; Granados-Soler JL; Pérez-Alenza MD
Vet Rec; 2016 Jul; 179(5):125. PubMed ID: 27377395
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment.
de M Souza CH; Toledo-Piza E; Amorin R; Barboza A; Tobias KM
Can Vet J; 2009 May; 50(5):506-10. PubMed ID: 19436636
[TBL] [Abstract][Full Text] [Related]
4. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy.
Tran CM; Moore AS; Frimberger AE
Vet Comp Oncol; 2016 Sep; 14(3):252-62. PubMed ID: 24735412
[TBL] [Abstract][Full Text] [Related]
6. Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours.
Sonzogni-Desautels K; Knapp DW; Sartin E; Doré M
Vet Comp Oncol; 2011 Sep; 9(3):161-71. PubMed ID: 21848619
[TBL] [Abstract][Full Text] [Related]
7. Use of surgery and carboplatin in feline malignant mammary gland neoplasms with advanced clinical staging.
De Campos CB; Nunes FC; Lavalle GE; Cassali GD
In Vivo; 2014; 28(5):863-6. PubMed ID: 25189900
[TBL] [Abstract][Full Text] [Related]
8. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel.
Simon D; Schoenrock D; Baumgärtner W; Nolte I
J Vet Intern Med; 2006; 20(5):1184-90. PubMed ID: 17063714
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Thalidomide and Metronomic Chemotherapy for the Treatment of Canine Malignant Mammary Gland Neoplasms.
DE Campos CB; Lavalle GE; Monteiro LN; Pêgas GRA; Fialho SL; Balabram D; Cassali GD
In Vivo; 2018; 32(6):1659-1666. PubMed ID: 30348731
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
12. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008).
Marconato L; Romanelli G; Stefanello D; Giacoboni C; Bonfanti U; Bettini G; Finotello R; Verganti S; Valenti P; Ciaramella L; Zini E
J Am Vet Med Assoc; 2009 Oct; 235(8):967-72. PubMed ID: 19827983
[TBL] [Abstract][Full Text] [Related]
14. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade.
Hermo GA; Turic E; Angelico D; Scursoni AM; Gomez DE; Gobello C; Alonso DF
J Am Anim Hosp Assoc; 2011; 47(1):21-7. PubMed ID: 21164169
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
Brockley LK; Cooper MA; Bennett PF
N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of regional lymph node status in canine mammary carcinomas.
Szczubiał M; Łopuszynski W
Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
[TBL] [Abstract][Full Text] [Related]
19. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.
Polton G; Finotello R; Sabattini S; Rossi F; Laganga P; Vasconi ME; Barbanera A; Stiborova K; Rohrer Bley C; Marconato L
Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
